SINT on Nasdaq

Sintx Technologies, Inc.

American surgical and medical instruments and apparatus company.

Price unavailable

Last updated Oct 18, 2026.

Overview

Compare with RenovoRx, Inc., PetVivo Holdings, Inc. or SeaStar Medical Holding Corp, or pick any stock.

  • TickerSINT on Nasdaq
  • IndustrySurgical & Medical Instruments & Apparatus
  • HeadquartersDE
  • Incorporated inDE2
  • Business address1885 West 2100 Street, Salt Lake City, Ut 841192
  • Filer categoryNon-accelerated filer, Smaller reporting company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

45.3%Gross margin3
-1053.1%Operating margin3
-1018.1%Net margin3
-64.7%Revenue growth, 20253
-353.8%Return on equity3
-$8.8MFree cash flow3

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Product brought in 72% of the revenue Sintx Technologies, Inc. broke down this way in fiscal 2025.

  1. Product$729.0K372%down 41% from 2024
  2. Grant and Contract$289.0K328%down 82% from 2024
Products and services by year
Products and services20242025
Product$1.2M$729.0K
Grant and Contract$1.6M$289.0K

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue11¢$557.0K
  • Research and development89¢$4.6M

Out of $1.0M in revenue.3 The company lost money this year.

Financial statements

Revenue456783$1.0M in 2025+48% since 2019
0$1.0M$2.0M$3.0M2019: $689.0K$689.0K20192020: $594.0K$594.0K2020−14%2021: $606.0K$606.0K2021+2%2022: $1.6M$1.6M2022+158%2023: $2.6M$2.6M2023+68%2024: $2.9M$2.9M2024+10%2025: $1.0M$1.0M2025−65%
Gross profit456783$461.0K in 2025+234% since 2019
0$1.0M$2.0M$3.0M2019: $138.0K$138.0K20192020: $119.0K$119.0K2020−14%2021: $157.0K$157.0K2021+32%2022: $1.3M$1.3M2022+725%2023: $1.8M$1.8M2023+42%2024: $2.1M$2.1M2024+13%2025: $461.0K$461.0K2025−78%
Operating income456783-$10.7M in 2025+63% since 2019
-$15.0M-$10.0M-$5.0M02019: -$6.6M-$6.6M20192020: -$8.5M-$8.5M2020+29%2021: -$10.6M-$10.6M2021+25%2022: -$11.3M-$11.3M2022+7%2023: -$13.4M-$13.4M2023+18%2024: -$14.0M-$14.0M2024+5%2025: -$10.7M-$10.7M2025−24%
Net income456783-$10.4M in 2025+116% since 2019
-$15.0M-$10.0M-$5.0M02019: -$4.8M-$4.8M20192020: -$7.0M-$7.0M2020+47%2021: -$9.3M-$9.3M2021+32%2022: -$12.0M-$12.0M2022+29%2023: -$8.3M-$8.3M2023−31%2024: -$11.0M-$11.0M2024+33%2025: -$10.4M-$10.4M2025−6%

Every line of the income statement as filed: the last 2 fiscal years, latest first.3

Period ending2025-12-312024-12-31
Total revenue$1.0M$2.9M
Cost of revenue$557.0K$811.0K
Gross profit$461.0K$2.1M
Research and development$4.6M$5.2M
General and administrative$6.2M$4.0M
Sales and marketing$242.0K$614.0K
Armor exit costs$4.6M
Reduction in force$407.0K
Grant and contract expenses$156.0K$1.3M
Total operating expenses$11.2M$16.1M
Loss from operations-$10.7M-$14.0M
Interest expense-$52.0K-$29.0K
Interest income$175.0K$107.0K
Gain (loss) on the disposal of assets$327.0K-$19.0K
Change in fair value of derivative liabilities-$124.0K$3.5M
Offering costs of derivative liabilities-$550.0K
Other income (expense)$31.0K$39.0K
Total other income (expense), net$357.0K$3.0M
Net loss before income taxes-$10.4M-$11.0M
Net loss-$10.4M-$11.0M
Deemed dividend related to warrant inducement-$6.7M
Net loss attributable to common stockholders-$17.1M-$11.0M
Basic net loss-$4-$15
Basic deemed dividend related to warrant inducement-$2
Basic attributable to common stockholders-$6.16-$14.87
Diluted net loss-$4-$15
Diluted - deemed dividend related to warrant inducement-$2
Diluted attributable to common stockholders-$6.16-$15.19
Basic2.8M shares741.2K shares
Diluted2.8M shares744.8K shares

Compare Sintx Technologies, Inc. with another company

Leadership

Who has led Sintx Technologies, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Bhajanjit Bal2015–2017

President

  1. Bhajanjit Bal2015–2016
  2. Robert Ryan Elmore2026–now

Chief financial officer

  1. Jay M. Moyes2014
  2. Ty Lombardi2016
  3. Kevin Trask2025–now

Chief operating officer

  1. Kevin Davis2014
  2. David Francis O'Brien2020
201520202025
Board members and other officers (16)

Former names

  • AMEDICA CORPDec 31, 2012 to Oct 5, 20182

Timeline

  1. Jan 9, 2015New chief executive Bhajanjit Bal becomes CEO11

Filings

195 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 64 major events, 25 insider forms, 18 large holders, 68 other. The latest 20:

  1. Oct 9, 20268-K EDGAR
  2. Oct 1, 20268-K EDGAR
  3. Aug 18, 2026EFFECT EDGAR
  4. Aug 13, 20268-K EDGAR
  5. Aug 13, 2026S-3 EDGAR
  6. Aug 13, 2026SCHEDULE 13G EDGAR
  7. Aug 11, 20268-K EDGAR
  8. Aug 11, 202610-Q EDGAR
  9. Jul 23, 20268-K EDGAR
  10. Jul 2, 20268-K EDGAR
  11. Jun 30, 2026EFFECT EDGAR
  12. Jun 25, 2026S-3 EDGAR
  13. Jun 9, 2026SCHEDULE 13G EDGAR
  14. Jun 9, 2026SCHEDULE 13G EDGAR
  15. Jun 3, 20268-K EDGAR
  16. May 27, 20268-K EDGAR
  17. May 15, 202610-Q EDGAR
  18. Apr 14, 20264 EDGAR
  19. Mar 20, 202610-K EDGAR
  20. Mar 18, 20264 EDGAR

The 195 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last three years, summarized. The full record is on SEC EDGAR.

Insider trades and holders

Large holders

Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 18 such filings since October 2021, the latest 10:

  1. Aug 13, 2026SCHEDULE 13G
  2. Jun 9, 2026SCHEDULE 13G
  3. Jun 9, 2026SCHEDULE 13G
  4. Dec 9, 2025SCHEDULE 13G
  5. Nov 14, 2025SCHEDULE 13G
  6. Nov 14, 2025SCHEDULE 13G/A
  7. Sep 3, 2025SCHEDULE 13G
  8. Jul 3, 2025SCHEDULE 13G
  9. May 15, 2025SCHEDULE 13G/A
  10. Mar 25, 2025SCHEDULE 13G

From Forms 4 and Schedules 13D and 13G filed with the SEC.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Bleichroeder LP523,013$978.0K0.2%New
Stonepine Capital Management, LLC209,205$332.5K0.3%New
Veracity Capital LLC76,674$143.4K0.0%No change
Citadel Advisors LLC31,930$59.7K0.0%New
Geode Capital Management, LLC30,101$56.3K0.0%−2,043
Vanguard Fiduciary Trust Co23,531$44.0K0.0%No change
Vanguard Capital Management LLC20,905$39.1K0.0%No change
State Street Corp13,302$24.9K0.0%No change
UBS Group AG11,921$22.3K0.0%+6,968
Virtus Wealth Solutions LLC10,000$18.7K0.0%No change
Tower Research Capital LLC (TRC)2,850$5.3K0.0%+1,683
Signaturefd, LLC1,717$3.2K0.0%+572
SBI Securities Co., Ltd.14$260.0%No change
Hrt Financial LP12,831$230.0%New
Morgan Stanley1$20.0%−17
National Bank Of Canada /fi/1$20.0%No change
Allworth Financial LP1$20.0%No change
Osaic Holdings, Inc.1$20.0%−1
Cornerstone Planning Group LLC1$20.0%No change
Royal Bank Of Canada39$00.0%No change

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31